ArticleFrontiers in immunology2023

Conformation-selective rather than avidity-based binding to tumor associated antigen derived peptide-MHC enables targeting of WT1-pMHC low expressing cancer cells by anti-WT1-pMHC/CD3 T cell engagers.

Even Walseng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.